Loading clinical trials...
Loading clinical trials...
The Effectiveness of Weizmannia Coagulans BC99 in Alleviating Allergic Rhinitis in Adults and Its Impact on the Gut Microbiota
Conditions
Interventions
Probiotic
Placebo
Locations
1
China
School of Food and Bioengineering, Henan University of Science and Technology
Luoyang, Henan, China
Start Date
November 2, 2024
Primary Completion Date
December 28, 2024
Completion Date
February 25, 2025
Last Updated
March 20, 2025
NCT06732414
NCT05494346
NCT06061848
NCT06603935
NCT06151938
NCT05186025
Lead Sponsor
Wecare Probiotics Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions